Thriveworks - Medicare Mental Health Clinic in Fort Lauderdale, FL

Thriveworks is a medicare enrolled mental health clinic (Counselor - Mental Health) in Fort Lauderdale, Florida. The current practice location for Thriveworks is 2425 E Commercial Blvd Ste 405, Fort Lauderdale, Florida. For appointments, you can reach them via phone at (754) 400-5514. The mailing address for Thriveworks is 1000 Jefferson St Ste 2c, Lynchburg, Virginia and phone number is () -.

Thriveworks is licensed to practice in * (Not Available) (license number ). The clinic also participates in the medicare program and its NPI number is 1396360996. This medical practice accepts medicare insurance (which means this clinic accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance). However, please confirm if they accept your insurance at (754) 400-5514.

Contact Information

Thriveworks
2425 E Commercial Blvd Ste 405
Fort Lauderdale
FL 33308-4029
(754) 400-5514
Not Available

Mental Health Clinic Profile

Full NameThriveworks
SpecialityCounselor
Location2425 E Commercial Blvd Ste 405, Fort Lauderdale, Florida
Authorized Official Name and PositionNathan M Miller (OWNER)
Authorized Official Contact5402176461
Accepts Medicare InsuranceYes. This clinic participates in medicare program and accept medicare insurance.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Thriveworks
1000 Jefferson St Ste 2c
Lynchburg
VA 24504-1724

Ph: () -
Thriveworks
2425 E Commercial Blvd Ste 405
Fort Lauderdale
FL 33308-4029

Ph: (754) 400-5514

NPI Details:

NPI Number1396360996
Provider Enumeration Date06/10/2020
Last Update Date12/29/2021
Certification Date12/29/2021

Medicare PECOS Information:

Medicare PECOS PAC ID5496173577
Medicare Enrollment IDO20200922002675

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Medical Identifiers

Medical identifiers for Thriveworks such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1396360996NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
101YM0800XCounselor - Mental Health (* (Not Available))Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Thriveworks acts as a billing entity for following providers:
Provider NameIan S Silbert
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1992747398
PECOS PAC ID: 3476505413
Enrollment ID: I20050217000535

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameMargaret Rowan Mortensen
Provider TypePractitioner - Clinical Psychologist
Provider IdentifiersNPI Number: 1538179692
PECOS PAC ID: 8325063118
Enrollment ID: I20051011000563

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NamePatricia M Dumont
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1952556060
PECOS PAC ID: 8123184108
Enrollment ID: I20090226000303

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameHeather Burroughs
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1891001004
PECOS PAC ID: 0244413631
Enrollment ID: I20110322000974

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameJessica S Campbell
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1265788137
PECOS PAC ID: 5799932976
Enrollment ID: I20120822000623

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameChristina Davis
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1740501915
PECOS PAC ID: 7214150291
Enrollment ID: I20140520001063

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameLourdes Caballero
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1639501620
PECOS PAC ID: 4789803982
Enrollment ID: I20140922000691

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameAndrea E Nutt
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1619335809
PECOS PAC ID: 2567740707
Enrollment ID: I20161024000748

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameSasha Navas
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1083056378
PECOS PAC ID: 0446533269
Enrollment ID: I20170201001789

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameLynn Howard
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1053767921
PECOS PAC ID: 1153606041
Enrollment ID: I20170315001589

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameLeslie Ann Lobel Juba
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1184160046
PECOS PAC ID: 3375820657
Enrollment ID: I20170516001092

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameEquilla Vonzetti Cherry
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1689029480
PECOS PAC ID: 9739474123
Enrollment ID: I20170825003094

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameKelechi U Ogbuji
Provider TypePractitioner - Psychiatry
Provider IdentifiersNPI Number: 1720336159
PECOS PAC ID: 0941590178
Enrollment ID: I20171219003181

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameKalvin Kapoor
Provider TypePractitioner - Psychiatry
Provider IdentifiersNPI Number: 1861829392
PECOS PAC ID: 2163788902
Enrollment ID: I20180130001502

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameJennifer Richie
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1063930121
PECOS PAC ID: 5698013696
Enrollment ID: I20190218001738

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameJane Arrington Dawson
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1679065858
PECOS PAC ID: 9234472978
Enrollment ID: I20190521002546

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameJulia B Murchison
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1467730499
PECOS PAC ID: 0143555334
Enrollment ID: I20190710002177

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameMarghani M Reever
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1376886671
PECOS PAC ID: 8729414529
Enrollment ID: I20200213002019

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameBrett Engle
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1922525831
PECOS PAC ID: 8820427511
Enrollment ID: I20200331003562

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameJessica L Faber
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1043828536
PECOS PAC ID: 1951728021
Enrollment ID: I20200903001709

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameKristi Gannon
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1952867111
PECOS PAC ID: 7214277961
Enrollment ID: I20200925001098

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameJessica Bailey
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1386019271
PECOS PAC ID: 7113346560
Enrollment ID: I20201005000071

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameMarcela Mejia
Provider TypePractitioner - Clinical Psychologist
Provider IdentifiersNPI Number: 1508308511
PECOS PAC ID: 3476973298
Enrollment ID: I20201016001609

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameJacqueline Nesci
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1659914430
PECOS PAC ID: 0941620447
Enrollment ID: I20201022002026

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameDelsondra Allen
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1083274708
PECOS PAC ID: 0840600714
Enrollment ID: I20201104000604

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameSamuel Robert Myrick
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1316496045
PECOS PAC ID: 2365852811
Enrollment ID: I20201111003078

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameJulienne Anna-carmelle Calixte
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1831795897
PECOS PAC ID: 9436561420
Enrollment ID: I20201216000928

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameIvy Lee
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1679199905
PECOS PAC ID: 9537572540
Enrollment ID: I20210113000372

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameEdna Petithomme
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1871090746
PECOS PAC ID: 4981017746
Enrollment ID: I20210115001520

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameMarion Marie Codling
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1205308376
PECOS PAC ID: 6406269117
Enrollment ID: I20210119000554

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameSheena Ausirus
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1346739356
PECOS PAC ID: 0345655098
Enrollment ID: I20210211000114

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameLeonie Ann Sistrat
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1912531799
PECOS PAC ID: 9436573763
Enrollment ID: I20210322001143

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameJillian K Wade
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1346835394
PECOS PAC ID: 0042627747
Enrollment ID: I20210325000055

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameKim Roberts
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1265014179
PECOS PAC ID: 1052720174
Enrollment ID: I20210430002400

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameSonia Choute-edouard
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1396347217
PECOS PAC ID: 8527467414
Enrollment ID: I20210526000680

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameKatherine D Danley
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1841498854
PECOS PAC ID: 3274779996
Enrollment ID: I20210608000107

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameGregg Steven Halverson
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1033776539
PECOS PAC ID: 6608277892
Enrollment ID: I20210625000111

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameCristian Rideaux
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1174176614
PECOS PAC ID: 1153726773
Enrollment ID: I20210819003722

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameBeata Sims
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1497159347
PECOS PAC ID: 7214159763
Enrollment ID: I20210830002401

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameRachael Cohen
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1477925360
PECOS PAC ID: 2860899614
Enrollment ID: I20210922000941

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameNicole Hill
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1235716697
PECOS PAC ID: 8729485115
Enrollment ID: I20210928002077

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameSonia Bain
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1871196337
PECOS PAC ID: 3173938446
Enrollment ID: I20210928002930

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameErkan Caygoz
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1356868160
PECOS PAC ID: 0547528218
Enrollment ID: I20211001000711

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameLinda Marie Lann
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1346825775
PECOS PAC ID: 4688072523
Enrollment ID: I20211007001837

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameAnzola Wiggins
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1154092245
PECOS PAC ID: 3173912342
Enrollment ID: I20211109000777

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameZishan Majeed
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1043981905
PECOS PAC ID: 9335538339
Enrollment ID: I20211112001560

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameAnton S Georgiev
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1639841299
PECOS PAC ID: 3779972484
Enrollment ID: I20211118002708

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameStephanie Jo Pierrenoel
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1184901902
PECOS PAC ID: 5092122978
Enrollment ID: I20211118002971

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameShannon Louise Schaal
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1013534205
PECOS PAC ID: 6800286196
Enrollment ID: I20211130002061

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameJermilla Augustin
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1811566581
PECOS PAC ID: 2769872555
Enrollment ID: I20211210000066

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameSharon Swaby
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1417618331
PECOS PAC ID: 6002125465
Enrollment ID: I20220126003212

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameMichael G Perez
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1336765460
PECOS PAC ID: 3072906080
Enrollment ID: I20220215000071

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameGlenda Ondina Collins
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1871189183
PECOS PAC ID: 2567858087
Enrollment ID: I20220411001402

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameStephen Hill
Provider TypePractitioner - Clinical Psychologist
Provider IdentifiersNPI Number: 1093749194
PECOS PAC ID: 6204214828
Enrollment ID: I20220609001290

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameKevin Atwell
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1528674603
PECOS PAC ID: 5294154464
Enrollment ID: I20220616001557

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameMichael Alexander-luz
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1427540814
PECOS PAC ID: 0840679890
Enrollment ID: I20220621003396

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameGavin V Malcolm
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1811669062
PECOS PAC ID: 9436530607
Enrollment ID: I20220719002359

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameNaida Ishamar Cruz
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1134872773
PECOS PAC ID: 1456733146
Enrollment ID: I20220727002253

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameGiovanny Zapata
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1104413038
PECOS PAC ID: 5395127369
Enrollment ID: I20220808001856

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameRomulo Mella
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1407934979
PECOS PAC ID: 3678957412
Enrollment ID: I20220829001915

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameKatelyn Horan
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1306580832
PECOS PAC ID: 5890177588
Enrollment ID: I20220830000298

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameShaheen Emmanuel Lakhan
Provider TypePractitioner - Psychiatry
Provider IdentifiersNPI Number: 1649585944
PECOS PAC ID: 4082937255
Enrollment ID: I20230105000230

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameSarajo Bunny Falk
Provider TypePractitioner - Clinical Psychologist
Provider IdentifiersNPI Number: 1336233352
PECOS PAC ID: 2860394012
Enrollment ID: I20230123000800

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameKhalilah Chantele Garrett
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1013495480
PECOS PAC ID: 2860899226
Enrollment ID: I20230125002106

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameSarah Shine
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1700405214
PECOS PAC ID: 0840678074
Enrollment ID: I20230206000013

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameSuzanne L Wright
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1285344515
PECOS PAC ID: 8123490760
Enrollment ID: I20230208002283

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameKatryne C Henry
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1750037511
PECOS PAC ID: 0446623318
Enrollment ID: I20230224001575

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameNicholas S Raines
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1023714151
PECOS PAC ID: 5698149771
Enrollment ID: I20230314000800

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameSindy Castro
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1184017014
PECOS PAC ID: 3173958683
Enrollment ID: I20230316001543

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameAlissa Meadow Myatt
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1427607357
PECOS PAC ID: 8325412158
Enrollment ID: I20230317002532

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameConnally Barry
Provider TypePractitioner - Clinical Psychologist
Provider IdentifiersNPI Number: 1700586138
PECOS PAC ID: 9931573623
Enrollment ID: I20230320002605

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameDanielle Marie Mickla
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1205523768
PECOS PAC ID: 1052776424
Enrollment ID: I20230508002948

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameErenis Olivia Rangel
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1831868231
PECOS PAC ID: 4981060308
Enrollment ID: I20230509002974

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameMelissa Santiago
Provider TypePractitioner - Clinical Psychologist
Provider IdentifiersNPI Number: 1952955734
PECOS PAC ID: 2769848753
Enrollment ID: I20230517002010

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameSusanna Nori Rowan
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1699466771
PECOS PAC ID: 2466819685
Enrollment ID: I20230602002322

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameBarbara Ann Center
Provider TypePractitioner - Psychiatry
Provider IdentifiersNPI Number: 1497909147
PECOS PAC ID: 5890781017
Enrollment ID: I20230804001285

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameSorcha Wool
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1417431701
PECOS PAC ID: 6204299126
Enrollment ID: I20230824004391

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameAnn Marie Alesia Harty
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1275227613
PECOS PAC ID: 3375907967
Enrollment ID: I20230915000006

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameDebra Fischer
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1124488093
PECOS PAC ID: 8123473428
Enrollment ID: I20231005003293

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameSeher Jangda
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1053875765
PECOS PAC ID: 2961850318
Enrollment ID: I20231127001350

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameFrederick Potter
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1174659726
PECOS PAC ID: 4183072531
Enrollment ID: I20231127001596

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameVirginia Martinsen
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1932840493
PECOS PAC ID: 4688022932
Enrollment ID: I20231127001835

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameSamantha Bickram
Provider TypePractitioner - Marriage And Family Therapist
Provider IdentifiersNPI Number: 1174254221
PECOS PAC ID: 6608224977
Enrollment ID: I20231127002450

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameVanessa Cumber
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1427444645
PECOS PAC ID: 3870941156
Enrollment ID: I20231127002990

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameElizabeth Wohlford
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1821771239
PECOS PAC ID: 9032567367
Enrollment ID: I20231128001429

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameLorna Wooten
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1881909612
PECOS PAC ID: 7113375353
Enrollment ID: I20231128002251

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameJuanita Bruno
Provider TypePractitioner - Marriage And Family Therapist
Provider IdentifiersNPI Number: 1093011041
PECOS PAC ID: 8022466267
Enrollment ID: I20231128002253

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameJaceline Celestin
Provider TypePractitioner - Marriage And Family Therapist
Provider IdentifiersNPI Number: 1245875707
PECOS PAC ID: 2264880426
Enrollment ID: I20231128002932

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameAna Jarzin
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1508267790
PECOS PAC ID: 1850749011
Enrollment ID: I20231128003086

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameJamie Jones
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1407099237
PECOS PAC ID: 7012365281
Enrollment ID: I20231128003182

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameGazaria Williams
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1760718415
PECOS PAC ID: 8729436993
Enrollment ID: I20231128003276

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameAmanda Buff
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1013416502
PECOS PAC ID: 7618325887
Enrollment ID: I20231128003363

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NamePaula Lowe-chin
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1881045888
PECOS PAC ID: 4981052156
Enrollment ID: I20231128003407

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameJarmela Carter
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1154680767
PECOS PAC ID: 9133577307
Enrollment ID: I20231128003543

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameRachel Spiller
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1972926723
PECOS PAC ID: 5294183471
Enrollment ID: I20231128003743

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameChad Jenkins
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1992131882
PECOS PAC ID: 9739537911
Enrollment ID: I20231128003771

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameVirginia Stegall
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1437443546
PECOS PAC ID: 4284082462
Enrollment ID: I20231128003797

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameAnn Taylor
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1124791991
PECOS PAC ID: 4183072366
Enrollment ID: I20231128003861

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameMaurianna Swanson
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1730581885
PECOS PAC ID: 4082062260
Enrollment ID: I20231128003910

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameWillow Goldfarb
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1659936524
PECOS PAC ID: 7810345022
Enrollment ID: I20231129001088

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameKate Jaramillo
Provider TypePractitioner - Marriage And Family Therapist
Provider IdentifiersNPI Number: 1104251651
PECOS PAC ID: 4587012703
Enrollment ID: I20231129001406

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameSarah Suarez
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1811488844
PECOS PAC ID: 0648628867
Enrollment ID: I20231129001528

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameGreta Wendorf
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1932815396
PECOS PAC ID: 9133577364
Enrollment ID: I20231129001806

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameDebora Chicungo Miranda
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1497400774
PECOS PAC ID: 0840648978
Enrollment ID: I20231129002286

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameSabrina Warner
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1558798728
PECOS PAC ID: 6608224746
Enrollment ID: I20231129002653

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameJennifer Marvin
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1215150420
PECOS PAC ID: 7214385350
Enrollment ID: I20231129002735

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NamePooja Vala
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1033825757
PECOS PAC ID: 7012365158
Enrollment ID: I20231129002830

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameBrett Burlone
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1366882904
PECOS PAC ID: 0143678292
Enrollment ID: I20231129003088

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameKathleen Gundlach
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1861912024
PECOS PAC ID: 1355799412
Enrollment ID: I20231129003394

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameLolita Carvallo
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1902204522
PECOS PAC ID: 9032567193
Enrollment ID: I20231129003566

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameRebecca Cantor
Provider TypePractitioner - Marriage And Family Therapist
Provider IdentifiersNPI Number: 1982301206
PECOS PAC ID: 7719335884
Enrollment ID: I20231129003798

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameHeather Payne
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1699062778
PECOS PAC ID: 1052769155
Enrollment ID: I20231130000751

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameMichael Petrosky Flores
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1437585098
PECOS PAC ID: 1254789357
Enrollment ID: I20231130001049

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameLisa Bishop
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1235166539
PECOS PAC ID: 4385092329
Enrollment ID: I20231130003120

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameAnna-maria Mazy
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1720553811
PECOS PAC ID: 5092163048
Enrollment ID: I20231130003265

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameAltagrace Gustave
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1619642519
PECOS PAC ID: 2062860026
Enrollment ID: I20231130003901

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameCatherine Bukovitz
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1881977106
PECOS PAC ID: 9234587221
Enrollment ID: I20231201000652

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameHarriet Zeikowitz
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1437825171
PECOS PAC ID: 8729436712
Enrollment ID: I20231201000922

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameSaundra Scott
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1538431119
PECOS PAC ID: 5799133781
Enrollment ID: I20231201001105

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameRicky Thompson
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1407194640
PECOS PAC ID: 3678921673
Enrollment ID: I20231201001264

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameMelanie Bartholomew
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1982379236
PECOS PAC ID: 9638527633
Enrollment ID: I20231201001409

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameDaniellys Diaz
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1649702168
PECOS PAC ID: 0749589166
Enrollment ID: I20231202000773

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameAyanna Facey
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1821411893
PECOS PAC ID: 4082062930
Enrollment ID: I20231202000778

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameDianne Gadishaw
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1487398806
PECOS PAC ID: 7618325564
Enrollment ID: I20231202000786

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameCandace Bennett
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1629798004
PECOS PAC ID: 5799133641
Enrollment ID: I20231203000079

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameDouglas Gorman
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1972848711
PECOS PAC ID: 6608224555
Enrollment ID: I20231203000086

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameJessica O'brien
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1578893285
PECOS PAC ID: 1052769957
Enrollment ID: I20231204001578

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameBromwell Reid
Provider TypePractitioner - Marriage And Family Therapist
Provider IdentifiersNPI Number: 1588300305
PECOS PAC ID: 3173971975
Enrollment ID: I20231204001909

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameDenise Ludwig-coe
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1780358267
PECOS PAC ID: 4183072986
Enrollment ID: I20231204002245

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameMargaret Keig
Provider TypePractitioner - Marriage And Family Therapist
Provider IdentifiersNPI Number: 1841550548
PECOS PAC ID: 2062860893
Enrollment ID: I20231204003304

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NamePedro Sam
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1467762245
PECOS PAC ID: 3274981014
Enrollment ID: I20231204003663

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameJeannie Marcelin
Provider TypePractitioner - Marriage And Family Therapist
Provider IdentifiersNPI Number: 1780062331
PECOS PAC ID: 4284083023
Enrollment ID: I20231206000070

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameJohn Phillip James
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1770986903
PECOS PAC ID: 3173918653
Enrollment ID: I20231206003076

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameGoulnissa Outechova
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1881145415
PECOS PAC ID: 0941659668
Enrollment ID: I20231206004107

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameStacey Santamarina
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1316284631
PECOS PAC ID: 5496104127
Enrollment ID: I20231206004182

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameHallie Kritsas
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1124403514
PECOS PAC ID: 3678922341
Enrollment ID: I20231207001542

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameRachel Block-stewart
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1013303965
PECOS PAC ID: 9638529415
Enrollment ID: I20231219003680

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameChristopher Michael Baird
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1992394084
PECOS PAC ID: 8820448418
Enrollment ID: I20231221004026

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameKaren J Allen
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1346672540
PECOS PAC ID: 9335599885
Enrollment ID: I20231222002683

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameShirley Barthelemy
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1669767190
PECOS PAC ID: 0941650386
Enrollment ID: I20231227000803

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameAmanda Romero
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1629733720
PECOS PAC ID: 3476903824
Enrollment ID: I20231227001236

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameAlice A Gilsinan
Provider TypePractitioner - Marriage And Family Therapist
Provider IdentifiersNPI Number: 1285125633
PECOS PAC ID: 8820448293
Enrollment ID: I20231227001712

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameGladys Amador
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1114491941
PECOS PAC ID: 5395195770
Enrollment ID: I20231227002016

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameEric Spinner
Provider TypePractitioner - Clinical Psychologist
Provider IdentifiersNPI Number: 1386412112
PECOS PAC ID: 6406206838
Enrollment ID: I20231228000575

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameMelissa Dobson
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1659434553
PECOS PAC ID: 6305296633
Enrollment ID: I20231228001010

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameKaren Porta
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1205573730
PECOS PAC ID: 9032569389
Enrollment ID: I20231228001792

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameLaura Coe
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1437665403
PECOS PAC ID: 3971953274
Enrollment ID: I20231228003736

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameLisa J Maddox
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1013632116
PECOS PAC ID: 8426408733
Enrollment ID: I20231228003751

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameStella Vidal
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1053001677
PECOS PAC ID: 2860842093
Enrollment ID: I20231229000881

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameVictoria L Baca Villagomez
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1144855925
PECOS PAC ID: 5991155152
Enrollment ID: I20231229001928

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameBetty Mhc Carrol
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1407415342
PECOS PAC ID: 1759732720
Enrollment ID: I20240104001222

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameDanielle Bishop
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1992349179
PECOS PAC ID: 7719338789
Enrollment ID: I20240104001357

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameOlivia Von Mering
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1336591338
PECOS PAC ID: 0749631125
Enrollment ID: I20240110002014

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NamePaige Whitley
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1952076788
PECOS PAC ID: 9537511431
Enrollment ID: I20240116003671

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameRosalie Beauchamp
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1548921430
PECOS PAC ID: 6204288079
Enrollment ID: I20240117001839

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameYanique Deane
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1194242016
PECOS PAC ID: 4385097161
Enrollment ID: I20240129000781

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameElizabeth Lindell Mendez
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1316618341
PECOS PAC ID: 7719330018
Enrollment ID: I20240201003287

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameKarie Ann Bliss
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1699311662
PECOS PAC ID: 7012351729
Enrollment ID: I20240221003415

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameAlexandria Renee Lodick
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1487430427
PECOS PAC ID: 7416392147
Enrollment ID: I20240304001891

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

Provider NameJaclyn Bencivenga
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1528507126
PECOS PAC ID: 8426494311
Enrollment ID: I20240314000494

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more Medical News

› Verified 3 days ago

News Archive

Low prevalence of SARS-CoV-2 specific antibodies in Lubbock, Texas

A recent study published in the Journal of Primary Care and Community Health has assessed the prevalence of antibodies developed specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in front-line workers in Lubbock, Texas. According to the study findings, immunoglobulin G (IgG)-specific anti-SARS-CoV-2 antibodies have been detected in only 0.73% of the participants.

Study finds markers of long-term brain injury in the blood of boxers and fighters

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Jacksonville, Fla., July 14 to 16, 2017.

Contraceptive sponge making a comeback

The contraceptive sponge initially launched in 1983 is now making a comeback ten years down the line.

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

Read more News

› Verified 3 days ago

Counselor in Fort Lauderdale, FL

Cmet, Llc
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 1527 Ne 4th Ave, Fort Lauderdale, FL 33304
Phone: 954-835-5741    Fax: 954-835-5746
Mercier Wellness And Consulting
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 101 Ne 3rd Ave, Suite 1500, Fort Lauderdale, FL 33301
Phone: 954-372-5892    
Acsi Community Behavioral Center, Llc.
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 3113 Stirling Rd Ste 204, Fort Lauderdale, FL 33312
Phone: 954-842-3501    Fax: 954-206-0906
Christopher Checke Lmhc Cap Llc
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 800 E Broward Blvd Ste 303, Fort Lauderdale, FL 33301
Phone: 954-240-6323    
Ocean Blue Counseling Group
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 2300 E Oakland Park Blvd, Suite 204, Fort Lauderdale, FL 33306
Phone: 724-799-1761    
Serinus Health Inc
Mental Health Clinic
Medicare: Medicare Enrolled
Practice Location: 648 Ne 25th Way, Fort Lauderdale, FL 33304
Phone: 703-470-4112    
E.g. Psychological Services, Pllc
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 313 Ne 2nd St Apt 1105, Fort Lauderdale, FL 33301
Phone: 917-216-9638    Fax: 833-478-1421

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.